Syros Reports Fourth Quarter 2019 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. SPY
2. DLR
3. EOSE
4. MU
5. AVAV
6. VSH
7. ENPH
8. AAPL
9. NVDA
10. PM

Go back to Syros Reports Fourth Quarter 2019 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

Syros Pharmaceuticals (SYRS) Tops Q4 EPS by 1c

March 5, 2020 7:32 AM EST

Syros Pharmaceuticals (NASDAQ: SYRS) reported Q4 EPS of ($0.46), $0.01 better than the analyst estimate of ($0.47).

We are entering 2020 in a position of strength, said Nancy Simonian, M.D., Chief Executive Officer of Syros. Following the recent initiation of our Phase 1 trial of SY-5609, we are advancing two... More